26 articles, transcripts, and reports
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President…
AngioDynamics Inc (NASDAQ:ANGO) Q3 2022 Earnings Call dated Apr. 07, 2022. Coporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President and…
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker’s net sales increased by 4%.…
Angiodynamics Inc (NASDAQ: ANGO) Q2 2022 earnings call dated Jan. 06, 2022 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge…
Angiodynamics Inc (NASDAQ: ANGO) Q1 2022 earnings call dated Sep. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President…
Angiodynamics Inc (NASDAQ: ANGO) Q4 2021 earnings call dated Jul. 13, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President…
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President and Chief…
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President and…
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief…
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and…
